These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
873 related items for PubMed ID: 15001272
1. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1268-79. PubMed ID: 15001272 [Abstract] [Full Text] [Related]
2. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1258-67. PubMed ID: 15001271 [Abstract] [Full Text] [Related]
6. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer. Choi Y, Kim JK, Lee HS, Hur WJ, Chai GY, Kang KM. Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):683-9. PubMed ID: 15927412 [Abstract] [Full Text] [Related]
7. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors. Hein PA, Gladstone DJ, Bellerive MR, Hug EB. Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1540-8. PubMed ID: 16029816 [Abstract] [Full Text] [Related]
10. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study. Marnitz S, Stuschke M, Bohsung J, Moys A, Reng I, Wurm R, Budach V. Strahlenther Onkol; 2002 Nov 01; 178(11):651-8. PubMed ID: 12426677 [Abstract] [Full Text] [Related]
11. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP. Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1173-80. PubMed ID: 19386423 [Abstract] [Full Text] [Related]
12. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Clark CH, Bidmead AM, Mubata CD, Harrington KJ, Nutting CM. Radiother Oncol; 2004 Feb 15; 70(2):189-98. PubMed ID: 15028407 [Abstract] [Full Text] [Related]
17. Hybrid IMRT for treatment of cancers of the lung and esophagus. Mayo CS, Urie MM, Fitzgerald TJ, Ding L, Lo YC, Bogdanov M. Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1408-18. PubMed ID: 18262730 [Abstract] [Full Text] [Related]
18. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors. Thomas E, Chapet O, Kessler ML, Lawrence TS, Ten Haken RK. Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):571-8. PubMed ID: 15890602 [Abstract] [Full Text] [Related]
19. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Yom SS, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Int J Radiat Oncol Biol Phys; 2007 May 01; 68(1):94-102. PubMed ID: 17321067 [Abstract] [Full Text] [Related]
20. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Hermanto U, Frija EK, Lii MJ, Chang EL, Mahajan A, Woo SY. Int J Radiat Oncol Biol Phys; 2007 Mar 15; 67(4):1135-44. PubMed ID: 17208388 [Abstract] [Full Text] [Related] Page: [Next] [New Search]